Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/11/2022
China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...
5/11/2022
NMPA Issues the 14th FYP for Drug Regulatory Network Safety and IT Bui...
5/11/2022
Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021
5/10/2022
NMPA Issues Two Guidelines for TCM Registration and Evaluation
5/10/2022
NMPA Solicits Comments on the Draft Implementation Rules for Drug Admi...
5/10/2022
Coherus Biosciences Terminates Deal With Innovent for Avastin Biosimil...
5/9/2022
SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021
5/9/2022
China's Pharma Companies Are Spending Big on R&D, But Global Success R...
5/9/2022
Chugai's Defeat in Patent Linkage Case Spotlights Invalidation Proceed...
5/6/2022
Trends in Innovative Drug Development in China (Nature)
5/6/2022
Upcoming Event: PHARM Connect Congress
5/6/2022
China Grants Approval and Generic Drug Status to CSPC's Alzheimer's Di...
5/6/2022
Orion Enters into Exclusive Deal with Jemincare for Novel Non-Opioid D...
5/6/2022
Drug R&D and Product Registration News Digest May 2022 (1)
5/6/2022
Recent Executive Moves
5/5/2022
EyePoint Signs Expanded License Deal with Betta Pharma for EYP-1901 in...
5/5/2022
China's 88 firms Including Sinovac Added to SEC List for Possible Deli...
5/4/2022
NiKang and Hansoh Announce Strategic Collaboration and License Deal fo...
5/4/2022
Intravacc Enters Licensing Deal with Zhifei Lvzhu Biopharma for Whoopi...
5/4/2022
BeiGene/Amgen Granted CN Conditional Approval of BLINCYTO (Blinatumo...
5/4/2022
How American Companies are Approaching China's Data, Privacy, and Cybe...
5/3/2022
International Cooperation Under China's Proposed Implementing Rules Fo...
5/3/2022
Navigating The Latest Changes In China's Regulation Of Human Genetic R...
5/2/2022
China in Lockdown Mode … Are Long Term Prospects and Bright Spots Sti...
5/2/2022
China Continues to Drop Reimbursements via DIP system: PBM
5/2/2022
U.S. FDA Snubs Two More China Only-Tested New Drugs from Hutchmed and ...
5/2/2022
Merck's MilliporeSigma Invests €100M to Accelerate Single-Use Manufac...
5/2/2022
Former GSK Scientist Convicted of Stealing Trade Secrets To Benefit Ch...
5/2/2022
Pfizer Wins Chinese Approval of lorlatinib for ALK-positive Advanced N...
4/29/2022
Novartis Reports Performance in Q1/2022 with China Business Up 16%
Page:
85
/
719
Total number of articles:
21546
:
[First]
[<<]
[83]
[84]
[85]
[86]
[87]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit